What type of study is this?

Revisiting the diagnostic and prosnotic performance of cyfra 21-1 and cea in non small cell lung cancer

View Full Paper

Ask AI

Bookmark

Authors

Retrospective study reveals moderate accuracy of Cyfra 21-1 and CEA for NSCLC diagnosis, suggesting potential for precise biomarker application.

Moderate diagnostic accuracy was observed for both CEA and CYFRA 21-1 in diagnosing NSCLC, indicating their clinical utility.
ROC analysis yielded AUC values of 0.78 for CEA and 0.82 for CYFRA 21-1, confirming their potential as reliable biomarkers.
Elevated levels of CEA and CYFRA 21-1 significantly predicted reduced survival in patients with NSCLC, highlighting urgency for early detection.
Subgroup analysis showed CYFRA 21-1 performed better in squamous cell carcinoma, while CEA excelled in poorly differentiated carcinoma.

Vo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective study reveals moderate accuracy of Cyfra 21-1 and CEA for NSCLC diagnosis, suggesting potential for precise biomarker application.